Longitudinal evaluation of adverse events due to steroid use in primary immune thrombocytopenia: A population‐based study

Documenti analoghi

• Comprehensive analysis and prediction model of mitophagy and ferroptosis in primary immune thrombocytopenia
  di: Jiani Mo, et al.
  Pubblicazione: (2024)
• Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid‐resistant immune thrombocytopenia
  di: Yuncui Yu, et al.
  Pubblicazione: (2025)
• Longitudinal plasma proteomics in romiplostim‐treated patients with immune thrombocytopenia
  di: Vivianne S. Nelson, et al.
  Pubblicazione: (2025)
• Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study
  di: Qing Wen, et al.
  Pubblicazione: (2024)
• Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia
  di: Tian‐shu Yu, et al.
  Pubblicazione: (2025)